Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    "Spirurida Infections"
Show Display Options
Rank Status Study
1 Active, not recruiting Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariasis
Interventions: Drug: 3 drug dose - IDA;   Drug: 2 drug dose - DA
2 Recruiting Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
Condition: Wuchereria Bancrofti Infection
Intervention: Drug: Ivermectin, Diethylcarbamazine Albendazole (IDA)
3 Completed An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis
Condition: Non-filarial Elephantiasis
Interventions: Other: Current skin care regimen plus 2% glycerine;   Other: Current skin care regimen
4 Completed Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali
Condition: Lymphatic Filariasis
Intervention: Drug: ''albendazole'' and ''ivermectin''
5 Recruiting Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
Condition: Schistosomiasis
Intervention: Drug: Praziquantel
6 Completed Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Conditions: Malaria;   Lymphatic Filariasis
Interventions: Drug: Ivermectin;   Drug: Albendazole
7 Recruiting Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
Conditions: Mansonella Perstans Infection;   Buruli Ulcer;   Tuberculosis;   Co-infection
Intervention: Drug: Doxycycline
8 Not yet recruiting Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
Condition: Onchocerciasis
Interventions: Drug: IVM plus ALB;   Drug: IVM
9 Recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin MDA
10 Recruiting Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
Condition: Lymphatic Filariasis
Interventions: Drug: Diethylcarbamazine;   Drug: Albendazole;   Drug: Ivermectin
11 Recruiting Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
12 Active, not recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis
Conditions: Lymphatic Filariasis;   Soil Transmitted Helminth Infections
Intervention: Drug: Albendazole and diethylcarbamazine
13 Withdrawn Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis
Conditions: Trachoma;   Lymphatic Filariasis
Interventions: Drug: azithromycin;   Drug: ivermectin;   Drug: albendazole;   Drug: placebo
14 Completed
Has Results
Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India
Condition: Lymphatic Filariasis
Intervention:
15 Unknown  Exhaled NO Testing in Filariasis
Condition: Filariasis
Intervention:
16 Completed Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
Conditions: Parasitic Diseases;   Bacterial Diseases
Intervention: Drug: triple co administration at once of the combination of Albendazole + ivermectin + azithromycin
17 Recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
18 Terminated
Has Results
Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi
Condition: Lymphatic Filariasis
Interventions: Drug: Albendazole 400mg and ivermectin 200mcg/kg;   Drug: Albendazole and ivermectin;   Drug: albendazole 800mg and ivermectin 400mcg/kg bi-annually
19 Completed Promoting Consistent Shoe Use Among Children At High Risk for Podoconiosis
Conditions: Podoconiosis;   Non-Filarial Elephantiasis
Intervention:
20 Active, not recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years